Back to top
more

NA (ZLTQ)

(Delayed Data from NSDQ)

$56.48 USD

56.48
3,119,757

0.00 (0.00%)

Updated Apr 27, 2017 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

IDEXX Laboratories (IDXX) Beats Q1 Earnings, Raises View

IDEXX Laboratories Inc. (IDXX) recorded first-quarter 2017 earnings per share (EPS) of 77 cents, up 51% (up 53% at constant exchange rate or CER) year over year on a reported basis.

    ResMed (RMD) Beats Q3 Earnings, Misses Sales Estimates

    ResMed Inc. (RMD) announced third-quarter fiscal 2017 adjusted earnings per share (EPS) of 71 cents, up 2.8% from the prior-year quarter level.

      Abaxis (ABAX) Beats Q4 Earnings Estimates, Revenues In Line

      Abaxis, Inc. (ABAX) reported fourth-quarter fiscal 2017 adjusted earnings per share of 33 cents, a penny ahead of the Zacks Consensus Estimate.

        Mead Johnson (MJN) Lags Q1 Earnings, Awaits Merger Closure

        Mead Johnson Nutrition Company (MJN) reported first-quarter 2017 adjusted earnings per share (EPS) of 80 cents at constant exchange rate or CER, down 8% year over year.

          Zimmer Biomet (ZBH) Beats on Q1 Earnings, Lowers Guidance

          Zimmer Biomet Holdings, Inc. (ZBH) reported first-quarter 2017 adjusted earnings per share (EPS) of $2.13, up 6% year over year.

            Boston Scientific (BSX) Misses on Q1 Earnings, Updates View

            Boston Scientific Corporation (BSX) posted adjusted EPS 29 cents in the first quarter, up 5.3% from the year-ago quarter.

              Conatus (CNAT) Catches Eye: Stock Moves Up 10% in Session

              Conatus Pharmaceuticals Inc. (CNAT) moved big last session, as its shares rose almost 10% on the day.

                Integra LifeSciences (IART) Misses Q1 Earnings, Retains View

                Integra LifeSciences Holdings Corporation (IART) reported adjusted earnings per share of 39 cents in the first quarter of 2017, which marked a 2.6% increase from the year-ago number.

                  Thermo Fisher (TMO) Tops Q1 Earnings, Sales, Raises Guidance

                  Thermo Fisher Scientific, Inc. (TMO) reported better-than-expected first-quarter 2017 earnings results.

                    Illumina (ILMN) Posts In-line Earnings in Q1, Margins Down

                    Illumina Inc. (ILMN) reported adjusted earnings per share (EPS) of 64 cents in the first quarter of 2017

                      Edwards Lifesciences (EW) Tops Q1 Earnings, Updates '17 View

                      Edwards Lifesciences Corp. (EW) reported first-quarter 2017 adjusted earnings per share (EPS) of 94 cents, which surpassed the Zacks Consensus Estimate by 14.6%.

                        NuVasive (NUVA) Beats on Q1 Earnings, Retains 2017 View

                        NuVasive, Inc. (NUVA) reported first-quarter 2017 adjusted earnings per share (EPS) of 38 cents, reflecting an 18.7% rise from the year-ago quarter.

                          LabCorp (LH) Tops Q1 Earnings, Misses on Sales, Tweaks View

                          Laboratory Corporation of America Holdings (LH) or LabCorp reported first-quarter 2017 adjusted earnings per share (EPS) of $2.22, up 8.3% from the year-ago quarter.

                            Zacks.com featured highlights: Heska, Zeltiq Aesthetics, YY, MaxLinear and Teradyne

                            Zacks.com featured highlights: Heska, Zeltiq Aesthetics, YY, MaxLinear and Teradyne

                              Rockwell Medical (RMTI) Catches Eye: Stock Moves Up 12.1%

                              Rockwell Medical, Inc. (RMTI) moved big last session, as its shares rose over 12% on the day.

                                Tirthankar Chakraborty headshot

                                Create an Efficient Portfolio with 5 Top Stocks

                                Price performance is believed to be positively correlated with efficiency level.

                                  GNC Holdings (GNC) Q1 Earnings & Revenues Top, Decline Y/Y

                                  GNC Holdings Inc. (GNC) reported first-quarter 2017 adjusted earnings per share (EPS) of 37 cents, reflecting a massive 46.4% year-over-year deterioration.

                                    Boston Scientific's Emerging Markets Grow Amid Currency Woes

                                    On Apr 11 2016, we issued an updated research report on leading medical devices company, Boston Scientific Corporation (BSX).

                                      Align (ALGN) Upgraded to Buy on Invisalign System Prospects

                                      On Apr 11, leading provider of dental and oral care solutions, Align Technology Inc. (ALGN) was raised to a Zacks Rank #2 (Buy).

                                        Haemonetics' Plasma Group Strong, Blood Center Group a Drag

                                        On Apr 11, we issued an updated research report on Braintree, MA-based Haemonetics Corporation (HAE), a leading provider of blood management solutions.

                                          ResMed's Study Results for Central Sleep Apnea Hold Promise

                                          ResMed Inc. (RMD) recently sponsored a study which shows potential treatment of obstructive sleep apnea (OSA) in patients with untreated central sleep apnea (CSA).

                                            Medtronic HVAD System Results Positive for Long-Term Therapy

                                            Medical device major Medtronic plc (MDT) recently released results of its ENDURANCE Supplemental trial in regard to HVAD System.

                                              IDEXX Laboratories' CAG Revenues Solid, Competition Rife

                                              On Apr 5, we issued an updated research report on Delaware NJ-based IDEXX Laboratories, Inc. (IDXX).

                                                Walgreens Boots (WBA) Meets Q2 Earnings, Retains EPS View

                                                Walgreens Boots Alliance, Inc. (WBA) reported adjusted earnings per share (EPS) of $1.36 in second-quarter fiscal 2017, up 6.1% year over year.

                                                  Walgreens, Prime Form Central Specialty & Mail Service Company

                                                  Walgreens Boots Alliance (WBA), in a partnership with pharmacy benefit manager (PBM) Prime Therapeutics LLC, recently formed a combined central specialty pharmacy and mail services company AllianceRx .